Keyword: Lonza

News

Christian Dowdeswell Joins Siegfried from Lonza

06.02.2023 -

As part of its growth strategy, Siegfried strengthens its management team and appoints Christian Dowdeswell as Chief Business Officer Drug Substances and member of the...

News

Lonza Completes HPAPI Expansion at Visp

29.09.2022 -

Lonza has completed of the expansion of its Highly Potent API (HPAPI) multipurpose suite at the Basel-based CDMO’s alpine production site in Visp, Switzerland, adding...

News

Lonza and Touchlight Collaborate on DNA

08.09.2022 -

Lonza has entered into a collaboration with Touchlight, a biotechnology company with patented technology for producing enzymatic DNA. The enzymatic manufacturing process...

News

Lonza Builds Swiss Fill & Finish Facility

08.07.2022 -

Swiss CDMO Lonza plans to build a large-scale commercial fill & finish facility in Stein. The new facility, to be located on the same campus as Lonza’s existing clinical...

News

Samsung Biologics in $81 Million Deal with Novartis

13.06.2022 -

In the their first-ever collaboration, South Korea’s Samsung Biologics and Switzerland’s Novartis have inked an initial $81 million contract manufacturing and development...

News

Lonza and Israel Biotech Fund Collaborate

30.05.2022 -

Lonza and Israel Biotech Fund (IBF) have signed a framework agreement, under which the Swiss CDMO will provide advice and support for Israeli biotech companies. IBF is...

Chemistry & Life Sciences

Integrated Drug Development Models

13.05.2022 -

Interview with Giovanna Libralon, Senior Director Commercial Development Small Molecules at Lonza.

News

Germany’s Merck Takes Lonza’s MAST Platform

06.04.2022 -

Germany’s Merck has acquired Lonza’s Modular Automated Sampling Technology (MAST) platform for an undisclosed sum. The Darmstadt-based chemicals, pharmaceuticals and life...